Categories: News

Neuronetics to Report First Quarter 2021 Financial and Operating Results and Host Conference Call

MALVERN, Pa., April 20, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that it plans to release first quarter financial and operating results prior to market open on Tuesday, May 4, 2021. The Company will host a conference call to review its results at 8:30 a.m. Eastern Time the same day.

The conference call will be broadcast live in listen-only mode via a webcast on the Company’s investor relations website at ir.neuronetics.com. To listen to the conference call on your telephone, please dial (877) 472-8990 for United States callers or +1 (629) 228-0778 for international callers and reference confirmation code 8667667, approximately ten minutes prior to start time. The replay will be available on the Company’s website for approximately 60 days.

About Neuronetics

Neuronetics, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Our first commercial product, the NeuroStar® Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The system is cleared by the United States Food and Drug Administration, or FDA, for the treatment of major depressive disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. Additional information can be found at www.neuronetics.com.

Investor Contact:

Mike Vallie or Mark Klausner
Westwicke Partners
443-213-0499
ir@neuronetics.com

Media Contact:

Chelsey Manko
Vault Communications
610-455-2778
cmanko@vaultcommunications.com

Staff

Recent Posts

ECP Completes Massive Growth Financing to Accelerate Investment in AI Platform for Assisted Living

MILWAUKEE--(BUSINESS WIRE)--#assistedliving--ECP, the leading software platform purpose-built for assisted living, announced today a significant growth…

24 minutes ago

Broadwood Partners Reiterates Opposition to STAAR Surgical’s Sale to Alcon Following Conclusion of Performative Go-Shop Process

Believes Belated Go-Shop Process Fails to Cure Fundamental Flaws in the Transaction’s Process, Timing, and…

25 minutes ago

Welldoc Partners with CLEAR to Integrate Secure Identity Verification in AI-Powered Cardiometabolic Health Platform

Collaboration Advances CMS Health Tech Ecosystem Goals by Enabling Seamless, Secure Access to Health Data…

3 hours ago

Both Ends Believing Celebrates 15 Years of Transforming Global Child Welfare Through Technology

DALLAS, Dec. 4, 2025 /PRNewswire/ -- Both Ends Believing (BEB), a Dallas-based global nonprofit with…

3 hours ago

Sage introduces skilled nursing solution to Sage Core, expanding its unified platform across all levels of senior care

Skilled brings wireless-first nurse call, real-time insights, and integrated workflows, completing Sage Core's support across…

3 hours ago

MJFF Initiates Funding for Emerging Therapeutic Targets in Parkinson’s Disease

NEW YORK, Dec. 8, 2025 /PRNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF)…

3 hours ago